Quantification of kynurenic acid in cerebrospinal fluid: effects of systemic and central L-kynurenine administration.
Heyes
M P
MP
Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD 20892.
Quearry
B J
BJ
D000163:Acquired Immunodeficiency Syndrome / Q000134:cerebrospinal fluid*; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D002946:Cisterna Magna / Q000187:drug effects; D006801:Humans; D007736:Kynurenic Acid / Q000134:cerebrospinal fluid*; D007737:Kynurenine / Q000008:administration & dosage / Q000494:pharmacology*; D008253:Macaca mulatta; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D015301:Retroviruses, Simian; D016097:Simian Acquired Immunodeficiency Syndrome / Q000134:cerebrospinal fluid*
D007737:Kynurenine; D007736:Kynurenic Acid